Investment analysts at StockNews.com initiated coverage on shares of Arcadia Biosciences (NASDAQ:RKDA – Get Free Report) in a research report issued to clients and investors on Thursday. The firm set a “sell” rating on the basic materials company’s stock.
Arcadia Biosciences Stock Performance
Shares of NASDAQ RKDA opened at $5.92 on Thursday. Arcadia Biosciences has a 1 year low of $1.85 and a 1 year high of $10.31. The firm has a market cap of $8.08 million, a price-to-earnings ratio of -1.38 and a beta of 1.19. The stock’s 50-day simple moving average is $4.54 and its 200-day simple moving average is $3.49.
About Arcadia Biosciences
Read More
- Five stocks we like better than Arcadia Biosciences
- What Are Dividends? Buy the Best Dividend Stocks
- Work and Play: Investing in the Rise of Bleisure Travel
- What does consumer price index measure?
- Top Dividend Stocks to Buy Now as Bond Yields Could Lower
- Canada Bond Market Holiday: How to Invest and Trade
- SAP: AI Tailwinds Accelerating Enterprise Cloud Business
Receive News & Ratings for Arcadia Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arcadia Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.